The donor experiences study

Improving donor experiences by assessing and responding to the fears of the individual donor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17256224

Enrollment

1200

Registered

2019-08-09

Start date

2019-08-14

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood donor health and management Not Applicable Blood donor

Interventions

Condition A: control group. Donation as usual. Condition B: fear assessment only. Donors will be asked to respond to an e-tablet-based question, prior to donating, relating to their f

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age =18 years and fulfilling Blood Service criteria for blood donation 2. 3 or less prior completed donations (plasma and/or whole-blood) 3. Willing and able to provide informed consent 4. Has a plasma or whole blood appointment (appointment made as a walk-in donor or previous appointment)

Exclusion criteria

Exclusion criteria: 1. Unwilling or unable to provide informed consent. 2. Lack of understanding of the English language necessary to complete questionnaires. 3. Contacted for a research study in the last 6 months as per Blood Service contact policy. 4. Donors with therapeutic, autologous, sample or platelet donation appointments.

Design outcomes

Primary

Measure	Time frame
1. Donor fear is measured using a self-report (France et al., 2013) at pre- and post-donation. 2. Donor anxiety is measured using the Blood Donor Anxiety Scale (Chell, Waller, & Masser, 2016; France et al., 2013) at post-donation. 3. Donor return at 6- and 12-month follow-up is measured using Australian Red Cross Blood Service records.	—

Secondary

Measure	Time frame
1. Self-reported vasovagal symptoms are measured using the Blood Donation Reactions Inventory (France, Ditto, France, & Himawan, 2008; Meade, France, & Peterson, 1996) at post-donation. 2 Staff recorded vasovagal reactions are measured using Australian Red Cross Blood Service standard procedures at any point at the donation centre. 3. Venipuncture pain is measured using a self-report at post-donation. 4. Donor self-efficacy is measured using a self-efficacy scale (France, Montalva, France & Trost, 2008) at post-donation. 5. Donor experience/satisfaction is measured using a self-report including Positive Support Scale (Brown et al., 2003; Hanson & France, 2009) at post-donation.	—

Measure

Time frame

1. Self-reported vasovagal symptoms are measured using the Blood Donation Reactions Inventory (France, Ditto, France, & Himawan, 2008; Meade, France, & Peterson, 1996) at post-donation. 2 Staff recorded vasovagal reactions are measured using Australian Red Cross Blood Service standard procedures at any point at the donation centre. 3. Venipuncture pain is measured using a self-report at post-donation. 4. Donor self-efficacy is measured using a self-efficacy scale (France, Montalva, France & Trost, 2008) at post-donation. 5. Donor experience/satisfaction is measured using a self-report including Positive Support Scale (Brown et al., 2003; Hanson & France, 2009) at post-donation.

—

Countries

Australia

Contacts

Public ContactPhilippe Gilchrist

philippe.gilchrist@mq.edu.au+61 2 9850 2340

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026